Vesicular Amine Transporter VMAT2 in the Rat Ileum: from Principal Mechanism to Clinical Applications by Stoyanova, I.I.
		
	  

	

 
		
	
 !"   67-72 
 
Research 
Vesicular Amine Transporter VMAT2 in the Rat Ileum: from 
Principal Mechanism to Clinical Applications 
Stoyanova II* 
Department of Clinical Neurophysiology, MIRA Institute for Biomedical Technology and Technical Medicine, 
University of Twente, Enschede, the Netherlands 
*Corresponding author:  Stoyanova II, Department of Clinical Neurophysiology (CNPH),  Faculty Science 
and Technology, MIRA Institute, University of Twente,  PO Box 217, 7500 AE,  Enschede, the Netherlands, 
Tel: 003153 489 5310; E-mail: stoyanovai@yahoo.co.uk 
Received date: 04 March 2015; Accepted date: 27 March 2015; Published date: 31 March 2015 
Citation: Stoyanova II. Vesicular Amine Transporter VMAT2 in the Rat Ileum: from Principal Mechanism to 
Clinical Applications. Exp Rev Immunol Vaccine Informat. 2015; 2 (1): 67-72. 
Copyright: © 2015 Stoyanova II.  Articles published in the journal are under open-access model distributed 
under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and 
reproduction in any medium, provided the original author and source are credited. 
 
Abstract 
Besides the role of a classical neurotransmitter, histamine plays a key role in the immune/inflammatory 
processes in the gastrointestinal tract. Specific transport proteins pack the amine neurotransmitters into vesicles 
so that their release can be regulated by neural activity. Recently, two vesicular amine transporters (VMAT1 and 
VMAT2), essential components of monoaminergic neurons and endocrine cells were identified. In our study we 
investigated VMAT2 distribution in the rat distal ileum using an immunocytochemical technique. VMAT2-
immunreactivity was found in neurons of the submucosal and myenteric plexuses, as well as in a dense network 
of nerve fibers.VMAT2-containing varicosities were numerous in the circular muscle layer and around the blood 
vessels. Some fibers and nerve terminals were observed beneath the epithelial cells.  
This data provide important information about the amine-handling structures in the distal gut. Moreover, it 
raises the possibility for development of new pharmacotherapeutic approach to inflammatory bowel diseases. 
Keywords: Gut innervation, Histamine transporters, VMAT2, Immunohistochemistry, Rat 
 
Introduction 
Besides the function of a classical neurotransmitter 
in the nervous system, the biogenic amine histamine 
(HIS) also plays a key role in the endocrine and 
immune/inflammatory system. In the gastrointestinal 
tract (GIT) HIS is a crucial mediator, and it was 
discovered to be responsible also for diarrhoea in 
inflammatory bowel diseases (IBD) and food allergy 
[1]. 
HIS-handling cells, like the other amine-handling 
cells, are characterized by synthesis, accumulation 
and secretion of the amine, which require amine-
synthesizing enzymes, plasma membrane 
transporters for amine intake, and intracellular 
transporters, named vesicular amine transporters 
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(VATs), for amine loading from the cytoplasm into 
secretory or synaptic vesicles [2]. Two structurally 
related but pharmacologically distinct monoamine 
transporters are known: VMAT1 and VMAT2 [3]. 
They act as an electrogenic exchanger of protons and 
monoamines, using a proton electrochemical 
gradient. Functional analysis showed that the two 
VATs differ in substrate recognition and inhibition 
by drugs [4,5]. VMAT2 has two to threefold higher 
affinity for most monoamine substrates than VMAT1 
[6]. In addition, VMAT1 and VMAT2 differ in their 
tissue distribution. While in the rat VMAT1 is a 
principal amine transporter of the PNS and of the 
neuroendocrine and mast cells, VMAT2 is expressed 
predominantly in the neuronal amine-handling cells: 
serotoninergic, noradrenergic, dopaminergic, 
histaminergic and adrenergic neurons of the CNS 
[7,8]. 
In humans, Erickson and collaborators [5] have 
demonstrated that all the chromogranin A-positive 
enterochromaffin (EC) cells of the stomach are 
VMAT2-positive, while in contrast, the majority of 
the intestinal EC cells are VMAT1-positive but 
VMAT2-negative. VMAT2 staining has been 
observed in the principal ganglion cells of the 
sympathetic nervous system, including the adrenal 
medulla [5]. In both rodent and human gut, most of 
the VMAT2 positive nerve fibers are found at the 
blood vessels’ wall and around the enteric ganglia 
[8]. These fibers represent projections of 
postganglionic sympathetic neurons. They are rare in 
the muscle and mucosal layers. According to Weihe 
and Eiden [7], VMAT2 positive neuronal perikarya 
are very rare or absent in the rodent gut, while 
Burger et al. have demonstrated them in the 
submucosal and myenteric plexus [9].  
Unlike the GABA and glutamate vesicular 
transporters, which are predominantly axonal [10], 
VMAT2 is expressed in the cell bodies and 
dendrites, as well as in axon terminals of monoamine 
neurons [11]. In axons, VMAT2 resides in synaptic 
vesicles and large dense-core vesicles (LDCVs) [12]. 
In dendrites and neuronal perikarya, the transporter 
is localized on tubulovesicular structures, and it is 
still unclear whether these membranes undergo 
regulated exocytosis [13]. 
Despite the fact that the biogenic amine-containing 
neuronal elements in the enteric nervous system 
(ENS) were quite extensively investigated, there are 
still some contradictions and several unanswered 
questions about their distributional pattern, chemical 
coding and function. Therefore, with this study we 
aimed at demonstrating VMAT2- ergicinnervation of 
the rat intestine. Additionally, we discuss their 
potential role in the etiopathogenesis of some 
diseases and prospective therapeutic implications. 
 
Material and Methods 
Animals and tissue preparation  
Seven adult Wistar rats (250-359 g body weight) 
were used in this study. All housing facilities and 
procedures used were approved by the Animal Care 
and Use Committee of the University of Twente, and 
were carried out in accordance with the European 
Communities Council Directive of 24 November 
1986. The rats were anesthetized and perfused with 
4% paraformaldehyde in 0.1 M PBS (pH 7.4). 
Specimens from the distal ileum were post fixed by 
immersion in the same fixative for 24 h at 4oC, and 
cryoprotected overnight in 25% sucrose in PBS at 
4oC. They were embedded in TissueTek OCT 
compound (Miles Inc., Elkhart, NI, USA), frozen, 
and 30 µm thick sections were cut in a cryostat at -
20oC. The specimens were investigated with 
immunocytochemical techniques for detection of 
VMAT2. 
Immunocytochemistry 
The immunostaining was performed according to the 
ABC (abiding-biotin-horseradish peroxidase) method 
[14]. Briefly, the endogenous peroxidase was 
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inactivated with hydrogen peroxide (0.3% in 
methanol/PBS for 30 min), and the background was 
blocked with 5% normal goat serum (NGS) and 1% 
bovine serum albumin (BSA) in 0.5% Triton X-100. 
Appropriate rinsing in PBS followed these and the 
subsequent procedures. Incubation in the primary 
antibodies (rabbit anti-VMAT2 IgG, Sigma-Aldrich, 
St. Louis, MO, USA) was for 20h at room 
temperature (RT), followed by treatment for 2h with 
biotinilated secondary antibody (goat anti-rabbit IgG, 
1:500; Jackson ImmunoResearch, West Grove, PA, 
USA). After rinsing, the slices were incubated for 1 h 
in ABC complex (Vector Labs, Burlingame, CA, 
USA, 6.25 µl/ml of each compound in PBS). The 
peroxidase activity was visualized using 2.4% SG 
substrate kit (Vector) in PBS for 5 minutes, at room 
temperature. All specimens were counterstained with 
0.5% Neutral red (Sigma-Aldrich). Finally, the slices 
were dehydrated in alcohol, cleared in xylene, and 
coverslipped with Entellan (Merck, Darmstadt, 
Germany).  
Negative controls included incubation at 4oC for 24h 
after antigen-antibody preabsorption with the native 
antigen SLC18A2 (Sigma-Aldrich), and replacement 
of the primary antibody with normal serum at the 
same concentration. 
 
Results 
In the distal ileum of rat the immunostaining for 
VMAT2 detection showed a small subpopulation of 
VMAT2-positive intrinsic enteric neurons in both the 
submucosal and myenteric plexuses (Figures 1-3). 
The staining revealed clearly distinguishable 
granular cytoplasmic pattern in those neurons. 
Additionally, they were surrounded by VMAT2-
immunolabelled nerve fibers (Figure 2). Varicose 
nerve fibers, which contain a high density of synaptic 
vesicles bearing the VMAT2 were present in all 
layers of the gut wall, markedly numerous in both 
the submucosal and myenteric plexuses (Fiures 3 
and 4). A high number of VMAT2-immunoreactive 
(IR) projections were found in the circular muscle 
layer (Figure 4). VMAT2-IR fibers formed a dense 
perivascular networks, particularly in the submucosa 
(Figure 5). In the mucosa, VMAT2-IR nerve fibers 
were distributed throughout the whole lamina 
propria, and outlined the intestinal glands (Figure 6). 
A large number of those fibres and terminals were in 
a close apposition to the glandular epithelial cells 
and to the smooth muscle cells of the intestinal villi 
(data not shown). No VMAT2-IR was found in the 
mucosal enteroendocrine (EC) cells of the ileum. 
 
Figure 1: Transverse section of the gut showing 
VMAT2-immunostaining in numerous varicose 
neuronal fibers in both the myenteric and 
submucosal plexus, and in all layers of the intestinal 
wall. X 400 
 
 
 
Figure 2: Photomicrograph of the distal ileum 
showing a VMAT2-positive neurone in the 
submucosal plexus (arrow). Note the numerous 
VMAT2-immunoreactive neuronal fibers in both the 
myenteric and submucosal plexuses (double arrows). 
X 400 
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Figure 3: Well expressed VMAT2-
immunoreactivity in a neurone (arrow) of the 
myenteric plexus surrounded by VMAT2-positive 
neuronal fibers. X 400 
 
 
Figure 4: Numerous neuronal projections, stained 
for VMAT2 in the circular muscle layer and in the 
submucosa (arrows). The glandular epithelium is 
delineated by VMAT2-containing varicosities (thin 
arrows). X 400 
 
 
 
Figure 5: Photomicrograph of a rat distal ileum. 
Thick VMAT2-immunolabelled neuronal processes 
surrounding blood vessels (arrows). X 400 
 
 
 
 
Figure 6: High-resolution micrograph of a section 
taken from the small intestine. A large number of 
VMAT2-containing neuronal processes (arrows) and 
terminals are found in a close apposition to the 
intestinal glands. X 400. 
 
Discussion 
The results from this study show that the rat distal 
ileum is innervated by VMAT2-expressing neuronal 
components. Our finding of small number of 
intrinsic monoaminergic neurons is in consent with 
the previously reported 1-2% of VMAT2-positive 
ganglionic cells in the lower part of the rat intestine 
[15,16]. These neurons have been identified as 
serotoninergic phenotype [17]. In the low part of the 
human gut, the mucosal and smooth muscle layers 
show very sparse VMAT2-labeled nerve fibers [15], 
however in the rat, as previously demonstrated [18] 
and also confirmed by this study, VMAT2-IR 
varicosities are quite abundant. It suggests that in 
rodents, the propulsive motor activity, secretion and 
active ion transport are under catecholaminergic 
control. Moreover, unlike the porcine ileum, where 
VMAT2-IR neuronal processes do not innervate 
blood vessels [19], in the rat we found quite 
abundant VAMT2-IR vascular innervations. This 
could be due to interspecies differences or 
differences in the staining procedures. The 
perivascular VMAT2-positive networks indicate that 
the mucosal blood flow is regulated by monoamines 
as well. Apparently, part of those neuronal fibres 
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originates from the intrinsic amine-handling 
ganglionic cell, however the other, particularly those 
innervating the blood vessels, probably represent 
terminals of postganglionic sympathetic 
(noradrenergic) neurons [8,18,20]. 
Additionally, amine-handling components of the 
ENS may also participate in some aspects of 
inflammation and immunity during pathological 
conditions [21]. The abundance of VMAT2-positive 
nerve fibers in the intestinal wall and the fact that 
HIS transporter VMAT2 can be inhibited by 
substances like ketanserin, reserpine or 
dicyclohexylcarbodiimide (DCCD), which clock 
various H+-translocating enzymes [22], suggest that 
HIS or VMAT2 antagonists may be used for 
pharmacological targeting of inflammatory bowel 
diseases. Moreover, it raises the possibility for 
development of new pharmacotherapeutic approach 
to them. 
The visualization of VMAT2-positive elements of 
the gut wall provides a potential for their imaging in 
the clinical context of disorders, related to them, 
particularly intestinal tumours. Since western 
blotting is not able to detect VMAT2 in normal 
ileum and colon, most likely due to the small number 
of VMAT2-expressing structures in them, the 
immunocytochemistry thus appears to be the most 
sensitive method with diagnostic potential in tumour 
pathology [23]. This method also allows an in situ 
exploration of plasticity, regulation, and 
degeneration of specific sets of amine-handling 
neurones, and the function of amine-handling 
inflammatory and immune cells. 
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